Metabolic-Fit / 100
CoreAge Rx review
One flat price, both molecules on a single chart, and a prescriber who reads your history before writing — the most predictable place for a mother to start and, just as important, to pause.
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Referral link, walled off from the score
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Every clinical figure in this piece is cited inline to its primary source — the trial or the FDA label — so you can open it and check us. This is background reading, not medical advice.
CoreAge Rx at a glance
- Semaglutide
- $99/mo
- Tirzepatide
- $149/mo
- Coverage
- All 50 states
- Brand-name
- Compounded only
How we scored CoreAge Rx
Every factor comes from CoreAge Rx's own published pricing, disclosures and oversight, and the six combine into the 92/100 Metabolic-Fit Score by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
Intake asks about pregnancy and nursing, and a clinician will discuss timing.
Both molecules on one account, so treatment can follow insulin resistance.
Named clinicians and pharmacies with real, verifiable oversight.
Among the most honest, predictable prices we track.
Follow-up, titration help, and messaging are part of the package.
Easy to pause and cancel — important when timing shifts.
How we verified this review
- Last verified
- August 2026
- Confidence
- high
- Primary source
- coreagerx.com
$99 for semaglutide and $149 for tirzepatide, flat at every dose — confirmed by walking the signup funnel rather than trusting the marketing page, where older 'starting at' phrasing still lingers. The funnel a reader is actually routed to is unambiguous, and both rates hold as the dose climbs.
What to expect when you sign up
We walked CoreAge Rx's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1Pick a molecule (semaglutide or tirzepatide) — both are shown up front with their flat monthly price
- 2Short medical-history intake (weight history, conditions, current meds, pregnancy/breastfeeding status)
- 3Asynchronous clinician review; a prescriber follows up if anything in your history needs a conversation
- 4Membership and shipping are set up before any charge; the price you saw is the price at checkout
What we noticed
- The flat price is visible before you start intake — no quiz-gating to see the number
- CoreAge dropped both prices since our last check — semaglutide from $149 to $99, tirzepatide from $349 to $149 — confirmed by walking the actual signup funnel, whose own FAQ states the price never scales with dose
- Intake explicitly asks about pregnancy, breastfeeding, and plans to conceive
- Both molecules live on one account, so switching later doesn't mean re-enrolling
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $99 | All doses (flat)One flat monthly price at every dose. |
| Compounded tirzepatide | $149 | All doses (flat)One flat monthly price at every dose. |
Swipe the table to see plan details →
Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what CoreAge Rx's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.
What we like
- A single flat monthly rate — no teaser first month that jumps at the first refill
- A prescriber reviews your history and will actually talk through timing if you're postpartum, nursing, or planning another pregnancy
- Semaglutide and tirzepatide on one chart, so switching molecules doesn't mean switching providers
- Covered in all 50 states, so a move for family doesn't interrupt care
The caveats
- Not the lowest sticker price — a couple of budget compounders come in under it
- Compounded only; there's no FDA-approved brand Wegovy or Zepbound lane here
- A general metabolic program, not a dedicated OB or hormone practice
Why CoreAge Rx tops the Metabolic-Fit ranking for mothers
Most GLP-1 telehealth is built to convert a first-time buyer, not to carry a mother through the timing questions that actually define her metabolic year — when to start after birth, whether to pause for a nursing stretch, how to move between molecules as PCOS or perimenopause shifts what her body does with insulin. CoreAge Rx earns the top Metabolic-Fit Score because it treats those questions as the point of the program, not the fine print. It won't be the cheapest line on this site, but at $99/month for compounded semaglutide it's close to the middle of what we track, and everything above the price is where it separates from the field.
A prescriber who reads your history — not an intake quiz
The single most useful thing a mother can get from a GLP-1 provider is a clinician who will actually look at her history before writing — a recent pregnancy, a plan to conceive again, a thyroid that's already in flux, a stretch of breastfeeding on the calendar. CoreAge's intake asks about pregnancy and breastfeeding up front, and a prescriber follows up when something in the record warrants a conversation rather than auto-approving the order. That is the opposite of the quiz-and-ship model most budget compounders run, and it's why the program scores highest on the two factors we weight most heavily for mothers: postpartum and breastfeeding guidance, and real clinical oversight.
To be clear about what that does and doesn't mean: no GLP-1 — compounded or brand — is established as safe during pregnancy or breastfeeding, and the labels advise against use. CoreAge doesn't change that, and a responsible provider shouldn't pretend to. What it offers is a clinician who will help you plan the timing around those windows with your own OB in the loop, which is a very different thing from a checkout flow that never asks.
Both molecules on one account — which matters more for mothers than it sounds
CoreAge carries compounded semaglutide and compounded tirzepatide on a single account, at a flat monthly price on each. For a general dieter that's a convenience. For a mother whose weight is driven by insulin resistance — the common thread through PCOS and a history of gestational diabetes — it's clinically relevant: tirzepatide's dual GIP/GLP-1 action is frequently the better-suited option there, and being able to switch without re-enrolling or hunting for a new provider means the treatment can follow the biology instead of the paperwork. If you want the deeper comparison, we walk through it in semaglutide vs tirzepatide for mothers.
Flat pricing, and an honest pause button
Two structural details do a lot of quiet work here. First, the price is flat across doses: it doesn't climb as you titrate up the way tiered plans quietly do, so the number you budget in month one is the number you're still paying at a full therapeutic dose. Second — and this is the part almost no provider markets — CoreAge is straightforward to pause. Mothers don't move in straight lines: a nursing stretch, a pregnancy, a hard season all argue for stopping cleanly and restarting later. A program you can step out of without a fight is worth more to a mother than a few dollars off a vial, and it's why CoreAge scores at the top on cancellation fairness.
Where CoreAge Rx isn't the answer
It's compounded, so if you specifically want an FDA-approved brand pen — Wegovy or Zepbound, with the manufacturer's own pregnancy and lactation labeling to hand your OB — CoreAge doesn't have that lane, and a physician-led, insurance-first program is the better starting point. It's also a general metabolic service, not a dedicated OB or hormone practice; the clinician access is real, but it isn't a maternal-fetal-medicine consult. And on raw sticker price, a couple of budget compounders undercut it. If price is the only lever you can move, weigh a lower-cost option against what you give up on oversight and continuity, and see where the rest of the field lands in our best GLP-1 for women ranking.
The bottom line
CoreAge Rx is the most predictable place for a mother to start a GLP-1 — and, just as importantly, the most predictable place to pause one. A prescriber who reads your history, both molecules on one flat-priced account, nationwide access so a move doesn't interrupt care, and a clean way to stop and restart add up to a program built for the way a mother's year actually runs, not the way a checkout flow wishes it did. It's our #1 pick, and the one we'd point a friend to first.
The bottom line for mothers
Best for: Mothers who want a fixed monthly price, a real clinician rather than an intake quiz, and uninterrupted nationwide access to both semaglutide and tirzepatide while they work out the timing around pregnancy or weaning.
Alternatives to CoreAge Rx
Providers we have a referral relationship with, ordered by their Metabolic-Fit Score — highest first. This module leaves out the provider whose page you are reading, so on CoreAge Rx's own review our #1 pick is the one name you will not find here. These are not the whole roster: see the full ranking for every provider we cover, paid or not.
- Visit Gala Health84
Metabolic-Fit / 100
A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included option if you can live with a yearly plan and a pharmacy it doesn't name.
- Visit Enhance MD81
Metabolic-Fit / 100
One of the more oversight-forward compounded programs here — lab work and a live provider visit bundled into every plan, with a gentle microdosing tier — the catch is that the low '$212' headline you'll see quoted is the 12-month prepay rate, not the $249 you'd pay month to month.
- Visit Sesame81
Metabolic-Fit / 100
A real telehealth marketplace with a video visit and a clinician you pick — now brand-first, so you get on-label Wegovy or Zepbound with the manufacturer's own pregnancy labeling, if you can absorb a membership fee stacked on the drug price.
Keep comparing CoreAge Rx
Head-to-head & alternatives
CoreAge Rx, answered
- Is CoreAge Rx safe to use while breastfeeding?
- No GLP-1 — compounded or brand — is established as safe during pregnancy or breastfeeding, and the labels advise against use. What sets CoreAge Rx apart for mothers is that its intake asks about breastfeeding and pregnancy plans up front, and a prescriber will talk through timing rather than auto-approving. Treat the medication as something to start after weaning, and use CoreAge's clinician access to plan that timing with your own OB in the loop.
- Does CoreAge Rx cover both semaglutide and tirzepatide?
- Yes — both molecules sit on a single account at a flat monthly price ($99 semaglutide, $149 tirzepatide as last verified). For mothers navigating PCOS or post-gestational-diabetes insulin resistance, that matters: tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, and you can move between the two without switching providers or re-enrolling.
- Why is CoreAge Rx ranked #1 for mothers?
- It earns the top Metabolic-Fit Score on the factors we weight most heavily for mothers: a real prescriber who reads your history (not an intake quiz), a flat price with no teaser-month step-up, both molecules on one chart, nationwide access so a move doesn't interrupt care, and a clean pause/cancel path — which is exactly what you want when timing around pregnancy or weaning is in play.
- Is CoreAge Rx compounded or brand-name?
- Compounded. That keeps the monthly price predictable and flat, but compounded semaglutide and tirzepatide are not FDA-approved finished products the way Wegovy or Zepbound are. If you specifically want an on-label brand pen with the manufacturer's own pregnancy and lactation labeling, that's the one thing CoreAge doesn't offer — a physician-led, insurance-first program is the better fit there.
Pricing, states and verification reflect CoreAge Rx's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.